Product Description
For Type 1 Diabetes Mellitus (Sourced from: https://clinicaltrials.gov/ct2/show/NCT02938572)
Mechanisms of Action: Unknown
Novel Mechanism: No
Modality: Unknown
Route of Administration: N/A
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Novo Nordisk
Company Location: Europe
Company Founding Year: 1923
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 1: Type 1 Diabetes
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT02938572 |
NN1406-4218 | P1 |
Completed |
Type 1 Diabetes |
2017-06-17 |
2019-03-21 |
Treatments |
|
NCT02612844 |
NN1406-4209 | P1 |
Completed |
Type 1 Diabetes |
2016-06-01 |
2019-03-20 |
Treatments |
Recent News Events
Date |
Type |
Title |
|---|